Medicare Enrolled

Dr. Hind Kettani, M.D.

Epilepsy Physician · Tampa, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3000 MEDICAL PARK DR STE 510, Tampa, FL 33613
8136157725
In practice since 2009 (16 years)
NPI: 1982832952 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kettani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kettani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kettani

Dr. Hind Kettani is an epilepsy physician in Tampa, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Kettani performed 355 Medicare services across 285 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kettani received a total of $105,340 from 81 pharmaceutical and/or device companies across 1060 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in epilepsy physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kettani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 44% volume in FL $105,340 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 137027 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
355
Medicare services
Top 44% in FL for epilepsy physician
285
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~22 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
84 $163 $615
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
79 $42 $167
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
79 $91 $382
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
59 $133 $534
New patient office visit, complex (60-74 min) 20 $148 $660
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $105 $498
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
16 $105 $397
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$105,340
Total received (2018-2024)
Avg $15,049/year across 7 years
Top 0% in FL for epilepsy physician
81
Companies
1,060
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$70,211 (66.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,477 (19.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,652 (13.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$39,198
2023
$26,599
2022
$12,929
2021
$6,626
2020
$13,289
2019
$6,119
2018
$580

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$29,355
JAZZ PHARMACEUTICALS INC.
$23,232
SK Life Science, Inc.
$18,586
LivaNova USA, Inc.
$8,932
Catalyst Pharmaceuticals, Inc.
$5,658
Jazz Pharmaceuticals Inc.
$4,742
ABBVIE INC.
$1,551
Sunovion Pharmaceuticals Inc.
$630
Greenwich Biosciences, Inc.
$541
Biogen, Inc.
$501
Teva Pharmaceuticals USA, Inc.
$467
Novartis Pharmaceuticals Corporation
$454
Lilly USA, LLC
$453
Amgen Inc.
$415
EISAI INC.
$411
GENZYME CORPORATION
$400
Allergan Inc.
$393
Biohaven Pharmaceuticals, Inc.
$389
Biohaven Pharmaceutical Holding Company Ltd.
$386
AbbVie Inc.
$385
PFIZER INC.
$374
Neurelis, Inc.
$369
Zyla Life Sciences
$349
Sumitomo Pharma America, Inc.
$340
Allergan, Inc.
$337
Eisai Inc.
$314
Takeda Pharmaceuticals U.S.A., Inc.
$306
NEUROPACE, INC.
$303
Avanir Pharmaceuticals, Inc.
$265
ACADIA Pharmaceuticals Inc
$255
US WorldMeds, LLC
$250
Alexion Pharmaceuticals, Inc.
$245
Lundbeck LLC
$240
Neurocrine Biosciences, Inc.
$232
EMD Serono, Inc.
$216
Supernus Pharmaceuticals, Inc.
$198
Marinus Pharmaceuticals, Inc.
$194
Harmony Biosciences LLC
$188
MITSUBISHI TANABE PHARMA AMERICA, INC.
$158
Azurity Pharmaceuticals, Inc.
$149
CSL Behring
$137
Acorda Therapeutics, Inc
$131
Celgene Corporation
$131
Gilead Sciences, Inc.
$121
CATALYST PHARMACEUTICALS, INC.
$97
AQUESTIVE THERAPEUTICS, INC.
$96
ARBOR PHARMACEUTICALS, INC.
$95
ARGENX US, INC.
$87
Horizon Therapeutics plc
$84
Upsher-Smith Laboratories LLC
$83
Almatica Pharma LLC
$82
Amneal Pharmaceuticals LLC
$79
HARMONY BIOSCIENCES LLC
$70
Merz North America, Inc.
$68
Alnylam Pharmaceuticals Inc.
$59
Bausch Health US, LLC
$57
Kyowa Kirin, Inc.
$55
Mallinckrodt Hospital Products Inc.
$50
BANNER LIFE SCIENCES, LLC
$49
GE HEALTHCARE
$44
Arbor Pharmaceuticals, Inc.
$42
IMPEL PHARMACEUTICALS INC.
$36
Promius Pharma LLC
$36
Zyla Life Sciences, Inc.
$36
Janssen Pharmaceuticals, Inc
$27
MERZ NORTH AMERICA, INC.
$26
NATUS MEDICAL INCORPORATED
$26
AstraZeneca Pharmaceuticals LP
$25
Chiesi USA, Inc.
$25
Corium, LLC
$23
IDORSIA PHARMACEUTICALS US INC
$22
AbbVie, Inc.
$22
Xeris Pharmaceuticals, Inc.
$21
Avadel CNS Pharmaceuticals, LLC
$21
ZOLL Respicardia, Inc.
$19
Collegium Pharmaceutical, Inc.
$19
Shionogi Inc
$16
E.R. Squibb & Sons, L.L.C.
$15
Grifols USA, LLC
$15
Egalet US Inc
$13
Mitsubishi Tanabe Pharma America, Inc.
$13
Top 3 companies account for 67.6% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · BAFIERTAM · BOTOX · BRILINTA · Briviact · CLEVIPREX · Cenobamate · DUOPA · Duopa · ELIQUIS · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Epidiolex · FYCOMPA · Fetroja · Fintepla · Fycompa · GAMMAGARD · GILENYA · GRALISE · GVOKE PFS · Gamunex-C · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LONHALA MAGNAIR · LUMRYZ · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAPRELAN · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · ONFI · ONPATTRO · OXTELLAR XR · PIPELINE-MS · PLEGRIDY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rystiggo · SOLIRIS · SPRIX · SYMPAZAN · Soliris · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Veklury · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · XYWAV · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZORVOLEX · ZTALMY · Zembrace SymTouch Sumatriptan Injection · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in epilepsy physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for epilepsy physician in FL.

Equivalent to $29,673 per 100 Medicare services performed
Looking for an epilepsy physician in Tampa?
Compare epilepsy physicians in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy physicians within 10 mi
2
Per 100K population
0.1
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kettani is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of FL peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kettani experienced with veeg monitoring, 12-26 hours with review?
Based on Medicare claims data, Dr. Kettani performed 84 veeg monitoring, 12-26 hours with review services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kettani receive payments from pharmaceutical companies?
Yes. Dr. Kettani received a total of $105,340 from 81 companies across 1,060 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kettani's costs compare to other epilepsy physicians in Tampa?
Dr. Kettani's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kettani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →